tm logo
SOLYMBIC
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 13 Jul 2020

Last Applicant/ Owned by

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

86971830 filed on 11th Apr 2016

Registration Number

N/A

Correspondent Address

Timothy J. Gaul

Amgen Inc.

One Amgen Center Drive

Trademark Operations-MS-28-5A

Thousand Oaks, CA 91320-1799

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SOLYMBIC

Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Mark Details


Serial Number

No 86971830

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-1489-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Jul 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
13th Jul 2020ABANDONMENT - NO USE STATEMENT FILED
19th Nov 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Nov 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
18th Nov 2019EXTENSION 5 GRANTED
13th Nov 2019TEAS EXTENSION RECEIVED
13th Nov 2019EXTENSION 5 FILED
28th May 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th May 2019EXTENSION 4 GRANTED
24th May 2019TEAS EXTENSION RECEIVED